Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) Non Operating Investment Income (2023 - 2026)

Orthofix Medical has reported Non Operating Investment Income over the past 5 years, most recently at -$16000.0 for Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Investment Income changed N/A year-over-year to -$16000.0, compared with a TTM value of -$64000.0 through Mar 2026, changed N/A, and an annual FY2025 reading of -$48000.0, down 100.94% over the prior year.
  • Non Operating Investment Income came in at -$16000.0 for Q1 2026, down from -$7000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $3.6 million in Q3 2024 to a low of -$260000.0 in Q1 2024.
  • Median Non Operating Investment Income over the past 4 years was -$7000.0 (2025), compared with a mean of $759666.7.
  • The sharpest move saw Non Operating Investment Income soared 731.47% in 2024, then tumbled 101.71% in 2025.
  • Over 4 years, Non Operating Investment Income stood at $1.4 million in 2023, then skyrocketed by 163.83% to $3.6 million in 2024, then plummeted by 100.2% to -$7000.0 in 2025, then plummeted by 128.57% to -$16000.0 in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Non Operating Investment Income are -$16000.0 (Q1 2026), -$7000.0 (Q4 2025), and -$10000.0 (Q3 2025).